Search Results - "Irtenkauf, Susan"

Refine Results
  1. 1

    Sox2 Promotes Malignancy in Glioblastoma by Regulating Plasticity and Astrocytic Differentiation by Berezovsky, Artem D, Poisson, Laila M, Cherba, David, Webb, Craig P, Transou, Andrea D, Lemke, Nancy W, Hong, Xin, Hasselbach, Laura A, Irtenkauf, Susan M, Mikkelsen, Tom, deCarvalho, Ana C

    Published in Neoplasia (New York, N.Y.) (01-03-2014)
    “…Abstract The high-mobility group–box transcription factor sex-determining region Y–box 2 (Sox2) is essential for the maintenance of stem cells from early…”
    Get full text
    Journal Article
  2. 2

    Optimization of Glioblastoma Mouse Orthotopic Xenograft Models for Translational Research by Irtenkauf, Susan M, Sobiechowski, Susan, Hasselbach, Laura A, Nelson, Kevin K, Transou, Andrea D, Carlton, Enoch T, Mikkelsen, Tom, deCarvalho, Ana C

    Published in Comparative medicine (01-08-2017)
    “…Glioblastoma is an aggressive primary brain tumor predominantly localized to the cerebral cortex. We developed a panel of patient-derived mouse orthotopic…”
    Get full text
    Journal Article
  3. 3

    Optimization of high grade glioma cell culture from surgical specimens for use in clinically relevant animal models and 3D immunochemistry by Hasselbach, Laura A, Irtenkauf, Susan M, Lemke, Nancy W, Nelson, Kevin K, Berezovsky, Artem D, Carlton, Enoch T, Transou, Andrea D, Mikkelsen, Tom, deCarvalho, Ana C

    Published in Journal of visualized experiments (07-01-2014)
    “…Glioblastomas, the most common and aggressive form of astrocytoma, are refractory to therapy, and molecularly heterogeneous. The ability to establish cell…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Neurochemical changes after acute binge toluene inhalation in adolescent and adult rats: A high-resolution magnetic resonance spectroscopy study by O'Leary-Moore, Shonagh K, Galloway, Matthew P, McMechan, Andrew P, Irtenkauf, Susan, Hannigan, John H, Bowen, Scott E

    Published in Neurotoxicology and teratology (01-11-2009)
    “…Abstract Inhalant abuse in young people is a growing public health concern. We reported previously that acute toluene intoxication in young rats, using a…”
    Get full text
    Journal Article
  6. 6
  7. 7

    CSIG-10. PLATELET-DERIVED GROWTH FACTOR RECEPTOR ALPHA ONCOGENE DEPENDENCY IN GLIOBLASTOMA by Berezovsky, Artem, Datta, Indrani, She, Ruicong, Transou, Andrea, Irtenkauf, Susan, Hasselbach, Laura, Poisson, Laila, deCarvalho, Ana

    Published in Neuro-oncology (Charlottesville, Va.) (12-11-2021)
    “…Abstract PDGFRA is the second most frequently amplified gene encoding receptor tyrosine kinase in adult glioblastoma (GBM), oftentimes as extrachromosomal…”
    Get full text
    Journal Article
  8. 8

    CSIG-06. PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA AS AN ONCOGENIC DRIVER IN GLIOBLASTOMA by Berezovsky, Artem, Irtenkauf, Susan, Transou, Andrea, Hasselbach, Laura, Mikkelsen, Tom, de Carvalho, Ana

    Published in Neuro-oncology (Charlottesville, Va.) (09-11-2020)
    “…Abstract Activated platelet derived growth factor receptor alpha (PDGFRα) is essential for the maintenance of oligodendrocyte progenitors. Differential…”
    Get full text
    Journal Article
  9. 9

    Abstract 1505: Platelet derived growth factor receptor alpha oncogene dependency in glioblastoma by Berezovsky, Artem D., Irtenkauf, Susan M., Transou, Andrea D., Hasselbach, Laura A., Mikkelsen, Tom, deCarvalho, Ana C.

    Published in Cancer research (Chicago, Ill.) (15-08-2020)
    “…Abstract Platelet-derived growth factor receptor alpha (PDGFRA) is a ligand-activated receptor tyrosine kinase (RTK) involved in neurodevelopment. In pediatric…”
    Get full text
    Journal Article
  10. 10

    Abstract 2519: Identification of novel MET fusion transcript amplification in glioblastoma by Nuga, Oluwademilade, deCarvalho, Ana, Meng, Yuling, Hasselbach, Laura, Nelson, Kevin, Irtenkauf, Susan, Transou, Andrea

    Published in Cancer research (Chicago, Ill.) (01-07-2018)
    “…Abstract Glioblastoma (GBM) is the most common and aggressive primary CNS malignant tumor with a 15.2% 2 year survival rate for tumors diagnosed between 2008…”
    Get full text
    Journal Article
  11. 11

    TMOD-06. HIGH INCIDENCE OF TUMORS AFTER TREATMENT WITH A DNA-ALKYLATING AGENT IN MOUSE STRAINS COMMONLY USED IN PRE-CLINICAL STUDIES by Irtenkauf, Susan, Hasselbach, Laura, Transou, Andrea, Poisson, Laila, Noushmehr, Houtan, Rybkin, Igor, deCarvalho, Ana

    Published in Neuro-oncology (Charlottesville, Va.) (05-11-2018)
    “…Abstract Glioblastoma (GBM) is commonly treated with the DNA-alkylating agent temozolomide (TMZ). Silencing O6-methylguanine-DNA methyltransferase (MGMT) by…”
    Get full text
    Journal Article
  12. 12
  13. 13

    TMOD-36. DEVELOPMENT OF A PATIENT-DERIVED ORTHOTOPIC XENOGRAFT GLIOBLASTOMA MODEL PHENOTYPICALLY REPRESENTATIVE OF THE CLINICAL FEATURES by Nagaraja, Tavarekere, deCarvalho, Ana, Griffith, Brent, Brown, Stephen, Divine, George, Irtenkauf, Susan, Knight, Robert, Lee, Ian, Panda, Swayamprava, Cabral, Glauber, Ewing, James

    Published in Neuro-oncology (Charlottesville, Va.) (11-11-2019)
    “…Abstract In murine models, patient derived orthotopic xenografts (PDOXs) generated from neurosphere cultures of human glioblastomas (GBMs) are unmatched in…”
    Get full text
    Journal Article
  14. 14

    Comparison of toluene-induced locomotor activity in four mouse strains by Bowen, Scott E., Kimar, Sarah, Irtenkauf, Susan

    Published in Pharmacology, biochemistry and behavior (01-04-2010)
    “…The mechanisms by which abused inhalants exert their neurobehavioral effects are only partially understood. In research with other drugs of abuse, specific…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Abstract 628: A method to examine spatial relationships between tumor cells and vasculature using a mouse orthotopic PDX glioblastoma model by Nagaraja, Tavarekere N., Keenan, Kelly, Irtenkauf, Susan, Hasselbach, Laura, Panda, Swayamprava, Cabral, Glauber, Ewing, James R., Mikkelsen, Tom, deCarvalho, Ana

    Published in Cancer research (Chicago, Ill.) (15-07-2016)
    “…Abstract Introduction: Glioblastoma progression requires angiogenesis and/or vascular co-option. A major pathway for its infiltration is the perivascular…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Treatment of TBI with collagen scaffolds and human marrow stromal cells increases the expression of tissue plasminogen activator by Mahmood, Asim, Qu, Changsheng, Ning, Riuzuo, Wu, Hongtao, Goussev, Anton, Xiong, Ye, Irtenkauf, Susan, Li, Yi, Chopp, Michael

    Published in Journal of neurotrauma (01-07-2011)
    “…This study examines the effects of combination therapy of collagen scaffolds and human marrow stromal cells (hMSCs) on the expression of tissue plasminogen…”
    Get more information
    Journal Article
  20. 20

    Abstract 427: Sox2 modulation of cancer stem cell behavior in GBM by Berezovsky, Artem D., Hong, Xin, Lemke, Nancy, Nelson, Kevin, Irtenkauf, Susan, Hasselbach, Laura, Mikkelsen, Tom, deCarvalho, Ana C.

    Published in Cancer research (Chicago, Ill.) (15-04-2012)
    “…Abstract Background and Objective: Glioblastoma (GBM) is the most aggressive primary brain tumor. GBM cells are phenotypically plastic and can present cancer…”
    Get full text
    Journal Article